CTI BioPharma Stock (NASDAQ: CTIC)
|Day Range5.58 - 6.01||52 Wk Range1.82 - 7.8||Open / Close5.91 / 5.63||Float / Outstanding105.2M / 114.4M|
|Vol / Avg.3.1M / 4.4M||Mkt Cap644M||P/E-||50d Avg. Price6.17|
|Div / Yield-||Payout Ratio-||Total Float105.2M||EPS-0.21|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of CTI BioPharma (NASDAQ: CTIC) through any online brokerage.
The latest price target for CTI BioPharma (NASDAQ: CTIC) was reported by Jefferies on Thursday, September 1, 2022. The analyst firm set a price target for 13.00 expecting CTIC to rise to within 12 months (a possible 130.91% upside). 7 analyst firms have reported ratings in the last year.
The stock price for CTI BioPharma (NASDAQ: CTIC) is $5.63 last updated September 29, 2022, 8:00 PM UTC.
There are no upcoming dividends for CTI BioPharma.
CTI BioPharma’s Q3 earnings are confirmed for Friday, November 11, 2022.
There is no upcoming split for CTI BioPharma.
CTI BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.